BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27219490)

  • 1. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk.
    Wang Q; Trevino LS; Wong RL; Medvedovic M; Chen J; Ho SM; Shen J; Foulds CE; Coarfa C; O'Malley BW; Shilatifard A; Walker CL
    Mol Endocrinol; 2016 Aug; 30(8):856-71. PubMed ID: 27219490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-193a targets MLL1 mRNA and drastically decreases MLL1 protein production: Ectopic expression of the miRNA aberrantly lowers H3K4me3 content of the chromatin and hampers cell proliferation and viability.
    Sengupta D; Deb M; Kar S; Parbin S; Pradhan N; Patra SK
    Gene; 2019 Jul; 705():22-35. PubMed ID: 31005612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.
    Duncan EM; Chitsazan AD; Seidel CW; Sánchez Alvarado A
    Cell Rep; 2015 Dec; 13(12):2741-55. PubMed ID: 26711341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minireview: Epigenomic Plasticity and Vulnerability to EDC Exposures.
    Walker CL
    Mol Endocrinol; 2016 Aug; 30(8):848-55. PubMed ID: 27355193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.
    Huo H; Magro PG; Pietsch EC; Patel BB; Scotto KW
    Cancer Res; 2010 Nov; 70(21):8726-35. PubMed ID: 20861184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Msk1 physically and functionally interacts with the KMT2A/MLL1 methyltransferase complex and contributes to the regulation of multiple target genes.
    Wiersma M; Bussiere M; Halsall JA; Turan N; Slany R; Turner BM; Nightingale KP
    Epigenetics Chromatin; 2016; 9():52. PubMed ID: 27895715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed-lineage leukaemia 1 contributes to endometrial stromal cells progesterone responsiveness during decidualization.
    Xiong Y; Wang Y; Ma L; Zhang Y; Qu X; Huang L; Wen X; Liu H; Zhang M; Zhang Y
    J Cell Mol Med; 2021 Jan; 25(1):297-308. PubMed ID: 33201593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental exposure to endocrine disrupting chemicals alters the epigenome: Identification of reprogrammed targets.
    Prusinski L; Al-Hendy A; Yang Q
    Gynecol Obstet Res; 2016 Jul; 3(1):1-6. PubMed ID: 27478869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
    Kim JY; Banerjee T; Vinckevicius A; Luo Q; Parker JB; Baker MR; Radhakrishnan I; Wei JJ; Barish GD; Chakravarti D
    Mol Cell; 2014 May; 54(4):613-25. PubMed ID: 24793694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.
    Zhou C; Zhang Y; Dai J; Zhou M; Liu M; Wang Y; Chen XZ; Tang J
    Sci Rep; 2016 Feb; 6():22066. PubMed ID: 26902498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased mixed lineage leukemia 1 is involved in endometriosis-related infertility.
    Wen X; Xiong Y; Liu H; Geng T; Jin L; Zhang M; Ma L; Zhang Y
    J Mol Endocrinol; 2021 Jan; 66(1):45-57. PubMed ID: 33151904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages.
    Carson WF; Cavassani KA; Soares EM; Hirai S; Kittan NA; Schaller MA; Scola MM; Joshi A; Matsukawa A; Aronoff DM; Johnson CN; Dou Y; Gallagher KA; Kunkel SL
    J Immunol; 2017 Sep; 199(5):1865-1874. PubMed ID: 28733487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.
    Dharmarajan V; Lee JH; Patel A; Skalnik DG; Cosgrove MS
    J Biol Chem; 2012 Aug; 287(33):27275-89. PubMed ID: 22665483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription.
    Blatter M; Meylan C; Cléry A; Giambruno R; Nikolaev Y; Heidecker M; Solanki JA; Diaz MO; Gabellini D; Allain FH
    Sci Adv; 2023 Apr; 9(16):eadf5330. PubMed ID: 37075125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer.
    Fagan RJ; Dingwall AK
    Cancer Lett; 2019 Aug; 458():56-65. PubMed ID: 31128216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL1/WDR5 complex in leukemogenesis and epigenetic regulation.
    Wu M; Shu HB
    Chin J Cancer; 2011 Apr; 30(4):240-6. PubMed ID: 21439245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLL1 is essential for the senescence-associated secretory phenotype.
    Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL
    Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.
    Riedel SS; Haladyna JN; Bezzant M; Stevens B; Pollyea DA; Sinha AU; Armstrong SA; Wei Q; Pollock RM; Daigle SR; Jordan CT; Ernst P; Neff T; Bernt KM
    J Clin Invest; 2016 Apr; 126(4):1438-50. PubMed ID: 26927674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLL1, a H3K4 methyltransferase, regulates the TNFα-stimulated activation of genes downstream of NF-κB.
    Wang X; Zhu K; Li S; Liao Y; Du R; Zhang X; Shu HB; Guo AY; Li L; Wu M
    J Cell Sci; 2012 Sep; 125(Pt 17):4058-66. PubMed ID: 22623725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLL1 promotes myogenesis by epigenetically regulating Myf5.
    Cai S; Zhu Q; Guo C; Yuan R; Zhang X; Nie Y; Chen L; Fang Y; Chen K; Zhang J; Mo D; Chen Y
    Cell Prolif; 2020 Feb; 53(2):e12744. PubMed ID: 31840352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.